tirzepatide surmount 4 for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial surmount 4 tirzepatide Continued Treatment

Lifters who are already fairly lean wonder if a tiny weekly dose of semaglutide or tirzepatide could help them get a sharper cut without the side effects reported at full therapeutic doses

In the initial study of semaglutide, in the second year patients lost on average an extra 8% of their body weight

Will I lose muscle on a GLP-1 medication

While side effects like rashes or itchiness can occur, the growing research around GLP-1s role in skin health is promising

Your immune system is broken up into two parts: the innate immune system and the adaptive immune system

8(2) doi: 10.1586/EEM.12.82 (2013) (Epub ahead of print) 15